Industry: Medical Devices & Consumables
Published Date: 2026-03-25
Pages: 118 Pages
Report ld: 6280779
Request Sample
Customized Report
Home Biomarker Testing Kits Market Size(US$)

CAGR 2026-2032
7.5%
Market Size,2032
USD 1,928
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Home Biomarker Testing Kits market size was US$ 1170 million in 2025 and is forecast to reach a readjusted size of US$ 1928 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Home Biomarker Testing Kits refers to devices and tools designed for individuals to measure specific biological markers (biomarkers) in the comfort of their homes. Biomarkers are measurable indicators of various physiological or pathological processes, or responses to treatment, and they provide insights into a person's health status.
In 2025, the North America Home Biomarker Testing Kits market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of Home Biomarker Testing Kits include Quest Diagnostics, 23andMe, Labcorp, Everlywell, Inc., PrivaPath Diagnostics, Vir Health Limited, Gene by Gene, BioSure Global Ltd, Home Test Box, YorkTest, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Home Biomarker Testing Kits market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Home Biomarker Testing Kits value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Blood Test
1.2.3 Saliva Test
1.2.4 Urine Test
1.2.5 Stool Test
1.2.6 Buccal Swab Test
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Home Biomarker Testing Kits Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Home Biomarker Testing Kits Market Share by Revenue, by Region (2021-2026)
2.4 Global Home Biomarker Testing Kits Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Home Biomarker Testing Kits Market Size and Prospective (2021-2032)
2.5.2 Europe Home Biomarker Testing Kits Market Size and Prospective (2021-2032)
2.5.3 China Home Biomarker Testing Kits Market Size and Prospective (2021-2032)
2.5.4 Japan Home Biomarker Testing Kits Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Home Biomarker Testing Kits Historical Market Size by Type (2021-2026)
3.2 Global Home Biomarker Testing Kits Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Home Biomarker Testing Kits
4 Breakdown Data by Application
4.1 Global Home Biomarker Testing Kits Historical Market Size by Application (2021-2026)
4.2 Global Home Biomarker Testing Kits Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Home Biomarker Testing Kits Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Home Biomarker Testing Kits Players by Revenue (2021-2026)
5.1.2 Global Home Biomarker Testing Kits Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Home Biomarker Testing Kits Revenue
5.4 Global Home Biomarker Testing Kits Market Concentration Analysis
5.4.1 Global Home Biomarker Testing Kits Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Home Biomarker Testing Kits Revenue in 2025
5.5 Global Key Players of Home Biomarker Testing Kits Head Offices and Areas Served
5.6 Global Key Players of Home Biomarker Testing Kits, Product and Application
5.7 Global Key Players of Home Biomarker Testing Kits, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Home Biomarker Testing Kits Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Home Biomarker Testing Kits Market Size by Type (2021-2026)
6.1.2.2 North America Home Biomarker Testing Kits Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Home Biomarker Testing Kits Market Size by Application (2021-2026)
6.1.3.2 North America Home Biomarker Testing Kits Market Share by Application (2021-2026)
6.1.4 North America Home Biomarker Testing Kits Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Home Biomarker Testing Kits Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Home Biomarker Testing Kits Market Size by Type (2021-2026)
6.2.2.2 Europe Home Biomarker Testing Kits Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Home Biomarker Testing Kits Market Size by Application (2021-2026)
6.2.3.2 Europe Home Biomarker Testing Kits Market Share by Application (2021-2026)
6.2.4 Europe Home Biomarker Testing Kits Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Home Biomarker Testing Kits Revenue by Company (2021-2026)
6.3.2 China Market Size by Type
6.3.2.1 China Home Biomarker Testing Kits Market Size by Type (2021-2026)
6.3.2.2 China Home Biomarker Testing Kits Market Share by Type (2021-2026)
6.3.3 China Market Size by Application
6.3.3.1 China Home Biomarker Testing Kits Market Size by Application (2021-2026)
6.3.3.2 China Home Biomarker Testing Kits Market Share by Application (2021-2026)
6.3.4 China Home Biomarker Testing Kits Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Home Biomarker Testing Kits Revenue by Company (2021-2026)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Home Biomarker Testing Kits Market Size by Type (2021-2026)
6.4.2.2 Japan Home Biomarker Testing Kits Market Share by Type (2021-2026)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Home Biomarker Testing Kits Market Size by Application (2021-2026)
6.4.3.2 Japan Home Biomarker Testing Kits Market Share by Application (2021-2026)
6.4.4 Japan Home Biomarker Testing Kits Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Key Player Profiles
7.1 Quest Diagnostics
7.1.1 Quest Diagnostics Company Details
7.1.2 Quest Diagnostics Business Overview
7.1.3 Quest Diagnostics Home Biomarker Testing Kits Introduction
7.1.4 Quest Diagnostics Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.1.5 Quest Diagnostics Recent Development
7.2 23andMe
7.2.1 23andMe Company Details
7.2.2 23andMe Business Overview
7.2.3 23andMe Home Biomarker Testing Kits Introduction
7.2.4 23andMe Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.2.5 23andMe Recent Development
7.3 Labcorp
7.3.1 Labcorp Company Details
7.3.2 Labcorp Business Overview
7.3.3 Labcorp Home Biomarker Testing Kits Introduction
7.3.4 Labcorp Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.3.5 Labcorp Recent Development
7.4 Everlywell, Inc.
7.4.1 Everlywell, Inc. Company Details
7.4.2 Everlywell, Inc. Business Overview
7.4.3 Everlywell, Inc. Home Biomarker Testing Kits Introduction
7.4.4 Everlywell, Inc. Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.4.5 Everlywell, Inc. Recent Development
7.5 PrivaPath Diagnostics
7.5.1 PrivaPath Diagnostics Company Details
7.5.2 PrivaPath Diagnostics Business Overview
7.5.3 PrivaPath Diagnostics Home Biomarker Testing Kits Introduction
7.5.4 PrivaPath Diagnostics Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.5.5 PrivaPath Diagnostics Recent Development
7.6 Vir Health Limited
7.6.1 Vir Health Limited Company Details
7.6.2 Vir Health Limited Business Overview
7.6.3 Vir Health Limited Home Biomarker Testing Kits Introduction
7.6.4 Vir Health Limited Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.6.5 Vir Health Limited Recent Development
7.7 Gene by Gene
7.7.1 Gene by Gene Company Details
7.7.2 Gene by Gene Business Overview
7.7.3 Gene by Gene Home Biomarker Testing Kits Introduction
7.7.4 Gene by Gene Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.7.5 Gene by Gene Recent Development
7.8 BioSure Global Ltd
7.8.1 BioSure Global Ltd Company Details
7.8.2 BioSure Global Ltd Business Overview
7.8.3 BioSure Global Ltd Home Biomarker Testing Kits Introduction
7.8.4 BioSure Global Ltd Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.8.5 BioSure Global Ltd Recent Development
7.9 Home Test Box
7.9.1 Home Test Box Company Details
7.9.2 Home Test Box Business Overview
7.9.3 Home Test Box Home Biomarker Testing Kits Introduction
7.9.4 Home Test Box Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.9.5 Home Test Box Recent Development
7.10 YorkTest
7.10.1 YorkTest Company Details
7.10.2 YorkTest Business Overview
7.10.3 YorkTest Home Biomarker Testing Kits Introduction
7.10.4 YorkTest Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.10.5 YorkTest Recent Development
7.11 Allworth Diagnostics
7.11.1 Allworth Diagnostics Company Details
7.11.2 Allworth Diagnostics Business Overview
7.11.3 Allworth Diagnostics Home Biomarker Testing Kits Introduction
7.11.4 Allworth Diagnostics Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.11.5 Allworth Diagnostics Recent Development
7.12 Aptatek Biosciences
7.12.1 Aptatek Biosciences Company Details
7.12.2 Aptatek Biosciences Business Overview
7.12.3 Aptatek Biosciences Home Biomarker Testing Kits Introduction
7.12.4 Aptatek Biosciences Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.12.5 Aptatek Biosciences Recent Development
7.13 Healthy Human Labs LTD
7.13.1 Healthy Human Labs LTD Company Details
7.13.2 Healthy Human Labs LTD Business Overview
7.13.3 Healthy Human Labs LTD Home Biomarker Testing Kits Introduction
7.13.4 Healthy Human Labs LTD Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.13.5 Healthy Human Labs LTD Recent Development
7.14 myLAB Box
7.14.1 myLAB Box Company Details
7.14.2 myLAB Box Business Overview
7.14.3 myLAB Box Home Biomarker Testing Kits Introduction
7.14.4 myLAB Box Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.14.5 myLAB Box Recent Development
7.15 Circa Biosciences
7.15.1 Circa Biosciences Company Details
7.15.2 Circa Biosciences Business Overview
7.15.3 Circa Biosciences Home Biomarker Testing Kits Introduction
7.15.4 Circa Biosciences Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.15.5 Circa Biosciences Recent Development
7.16 Enhance Diagnostics
7.16.1 Enhance Diagnostics Company Details
7.16.2 Enhance Diagnostics Business Overview
7.16.3 Enhance Diagnostics Home Biomarker Testing Kits Introduction
7.16.4 Enhance Diagnostics Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.16.5 Enhance Diagnostics Recent Development
7.17 In Vitro Diagnostic Solutions
7.17.1 In Vitro Diagnostic Solutions Company Details
7.17.2 In Vitro Diagnostic Solutions Business Overview
7.17.3 In Vitro Diagnostic Solutions Home Biomarker Testing Kits Introduction
7.17.4 In Vitro Diagnostic Solutions Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.17.5 In Vitro Diagnostic Solutions Recent Development
7.18 BTNX Inc.
7.18.1 BTNX Inc. Company Details
7.18.2 BTNX Inc. Business Overview
7.18.3 BTNX Inc. Home Biomarker Testing Kits Introduction
7.18.4 BTNX Inc. Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.18.5 BTNX Inc. Recent Development
7.19 Lab Me Analytics
7.19.1 Lab Me Analytics Company Details
7.19.2 Lab Me Analytics Business Overview
7.19.3 Lab Me Analytics Home Biomarker Testing Kits Introduction
7.19.4 Lab Me Analytics Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.19.5 Lab Me Analytics Recent Development
7.20 Complement
7.20.1 Complement Company Details
7.20.2 Complement Business Overview
7.20.3 Complement Home Biomarker Testing Kits Introduction
7.20.4 Complement Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.20.5 Complement Recent Development
7.21 Better2Know Limited
7.21.1 Better2Know Limited Company Details
7.21.2 Better2Know Limited Business Overview
7.21.3 Better2Know Limited Home Biomarker Testing Kits Introduction
7.21.4 Better2Know Limited Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.21.5 Better2Know Limited Recent Development
7.22 Personal Diagnostics Limited
7.22.1 Personal Diagnostics Limited Company Details
7.22.2 Personal Diagnostics Limited Business Overview
7.22.3 Personal Diagnostics Limited Home Biomarker Testing Kits Introduction
7.22.4 Personal Diagnostics Limited Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.22.5 Personal Diagnostics Limited Recent Development
7.23 Verisana Laboratories
7.23.1 Verisana Laboratories Company Details
7.23.2 Verisana Laboratories Business Overview
7.23.3 Verisana Laboratories Home Biomarker Testing Kits Introduction
7.23.4 Verisana Laboratories Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.23.5 Verisana Laboratories Recent Development
7.24 Zone Labs Inc.,
7.24.1 Zone Labs Inc., Company Details
7.24.2 Zone Labs Inc., Business Overview
7.24.3 Zone Labs Inc., Home Biomarker Testing Kits Introduction
7.24.4 Zone Labs Inc., Revenue in Home Biomarker Testing Kits Business (2021-2026)
7.24.5 Zone Labs Inc., Recent Development
8 Home Biomarker Testing Kits Market Dynamics
8.1 Home Biomarker Testing Kits Industry Trends
8.2 Home Biomarker Testing Kits Market Drivers
8.3 Home Biomarker Testing Kits Market Challenges
8.4 Home Biomarker Testing Kits Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Home Biomarker Testing Kits market is projected to grow from US$ 1170 million in 2025 to US$ 1928 million by 2032, at a CAGR of 7.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-25
Pages: 162
USD 4900.00
(Single User License)
The global Home Biomarker Testing Kits market was valued at US$ 1170 million in 2025 and is anticipated to reach US$ 1928 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 145
USD 2900.00
(Single User License)
The global market for Home Biomarker Testing Kits was estimated to be worth US$ 1170 million in 2025 and is projected to reach US$ 1928 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 155
USD 3950.00
(Single User License)
The global Home Biomarker Testing Kits market size was US$ 1096 million in 2024 and is forecast to a readjusted size of US$ 1806 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 111
USD 4250.00
(Single User License)
The global Home Biomarker Testing Kits market is projected to grow from US$ 1096 million in 2024 to US$ 1806 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-01
Pages: 167
USD 4900.00
(Single User License)
The global market for Home Biomarker Testing Kits was estimated to be worth US$ 1096 million in 2024 and is forecast to a readjusted size of US$ 1806 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 160
USD 3950.00
(Single User License)
The global market for Home Biomarker Testing Kits was valued at US$ 1096 million in the year 2024 and is projected to reach a revised size of US$ 1806 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published Date: 2025-03-10
Pages: 106
USD 2900.00
(Single User License)
The global Home Biomarker Testing Kits revenue was US$ 1020 million in 2023 and is forecast to a readjusted size of US$ 1691 million by 2030 with a CAGR of 7.5% during the review period (2024-2030).
Published Date: 2024-12-12
Pages: 138
USD 4350.00
(Single User License)
The global market for Home Biomarker Testing Kits was valued at US$ 1020 million in the year 2023 and is projected to reach a revised size of US$ 1691 million by 2030, growing at a CAGR of 7.5% during the forecast period.
Published Date: 2024-12-12
Pages: 101
USD 2900.00
(Single User License)
Valued at US$ 1096 million in 2024, the global Home Biomarker Testing Kits market is forecast to reach US$ 1691 million by 2030, at a CAGR of 7.5% during the forecast period.
Published Date: 2024-12-12
Pages: 170
USD 4900.00
(Single User License)
The global Home Biomarker Testing Kits market is projected to grow from US$ 1170 million in 2025 to US$ 1928 million by 2032, at a CAGR of 7.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-25
Pages: 162
The global Home Biomarker Testing Kits market was valued at US$ 1170 million in 2025 and is anticipated to reach US$ 1928 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-01-08
Pages: 145
The global market for Home Biomarker Testing Kits was estimated to be worth US$ 1170 million in 2025 and is projected to reach US$ 1928 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-01-08
Pages: 155
The global Home Biomarker Testing Kits market size was US$ 1096 million in 2024 and is forecast to a readjusted size of US$ 1806 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 111
The global Home Biomarker Testing Kits market is projected to grow from US$ 1096 million in 2024 to US$ 1806 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-01
Pages: 167
The global market for Home Biomarker Testing Kits was estimated to be worth US$ 1096 million in 2024 and is forecast to a readjusted size of US$ 1806 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 160
The global market for Home Biomarker Testing Kits was valued at US$ 1096 million in the year 2024 and is projected to reach a revised size of US$ 1806 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published: 2025-03-10
Pages: 106
The global Home Biomarker Testing Kits revenue was US$ 1020 million in 2023 and is forecast to a readjusted size of US$ 1691 million by 2030 with a CAGR of 7.5% during the review period (2024-2030).
Published: 2024-12-12
Pages: 138
The global market for Home Biomarker Testing Kits was valued at US$ 1020 million in the year 2023 and is projected to reach a revised size of US$ 1691 million by 2030, growing at a CAGR of 7.5% during the forecast period.
Published: 2024-12-12
Pages: 101
Valued at US$ 1096 million in 2024, the global Home Biomarker Testing Kits market is forecast to reach US$ 1691 million by 2030, at a CAGR of 7.5% during the forecast period.
Published: 2024-12-12
Pages: 170
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now